Can tumor uptake of [18F]afatinib in NSCLC patients be quantified, and does [18F]afatinib uptake identify patients who will benefit from afatinib therapy ?
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 28 Jul 2015
At a glance
- Drugs Afatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- 28 Jul 2015 New trial record